Reference

Breitenstein, C., Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E.B., Haeusler, K.G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., DeLangen, E., Rocker, R., Wigbers, F., Rühmkorf, C., Hempen, I., List, J., Baumgärtner, A. (2017). Intensive Speech and Language Therapy in Patients with Chronic Aphasia after Stroke: A Randomised, Open-Label, Blinded-Endpoint, Controlled Trial in a Health-Care Setting. The Lancet, 389, 1528-1538.

BibTeX

@article{ekn_bibtex_00369,
  title = {Intensive Speech and Language Therapy in Patients with Chronic Aphasia after Stroke: A Randomised, Open-Label, Blinded-Endpoint, Controlled Trial in a Health-Care Setting},
  author = {Breitenstein, C. and Grewe, T. and Fl{\"o}el, A. and Ziegler, W. and Springer, L. and Martus, P. and Huber, W. and Willmes, K. and Ringelstein, E.B. and Haeusler, K.G. and Abel, S. and Glindemann, R. and Domahs, F. and Regenbrecht, F. and Schlenck, K.-J. and Thomas, M. and Obrig, H. and DeLangen, E. and Rocker, R. and Wigbers, F. and R{\"u}hmkorf, C. and Hempen, I. and List, J. and Baumg{\"a}rtner, A.},
  year = {2017},
  journal = {The Lancet},
  volume = {389},
  pages = {1528--1538},
  doi = {http://dx.doi.org/10.1016/S0140-6736(17)30067-3}
}